Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00397111 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 444 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Re-verified, no change to tracked fields
  3. Minor Re-verified, no change to tracked fields
  4. Minor Eligibility criteria expanded, about 20 words
  5. Minor 8 versions Re-verified since Mar 28, 2026, no change to tracked fieldsv433-v440
Show 38 earlier versionsHide 38 earlier versions
  1. Minor Enrollment target: 340 to 390v432
  2. Minor 5 versions Re-verified since Nov 26, 2025, no change to tracked fieldsv427-v431
  3. Minor Study Status, Eligibilityv426
  4. Minor 31 versions Re-verified since Nov 8, 2024, no change to tracked fieldsv395-v425
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety disorders may cause structural and functional changes in the brain. This study will optimize the way MRI scans are collected to look at brain structure and examine how the brain behaves while subjects perform particular tasks. Healthy volunteers and individuals with major depressive disorder may be eligible for this study. Participants undergo magnetic resonance imaging (MRI) and neuropsychological testing. : Individuals will be asked to participate in an MRI study on one of several scanners. The scanner used will measure blood flow in the brain, concentrations of certain chemicals in the brain, or magnetic properties of the brain. The scan may involve They watching a screen presenting images or doing a task in which they respond to pictures or sounds. Participants may be asked to return for additional scans. The study also involves neuropsychological tests, which assess cognitive performance. Often, people with mood disorders have subtle changes in performance on these tests that allow researchers to pinpoint where brain abnormalities occur. Before the tests can be used in patients, they must be validated by using healthy subjects. These tests are presented either orally, in written form, or on a computer.
Trial Details
NCT Number NCT00397111
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions Mood Disorders, Anxiety Disorders
Enrollment 390 participants
Start Date
Updated on ClinicalTrials.gov